A plant-based treatment for Alzheimer's disease?
Researchers are constantly looking for new ways to treat Alzheimer's disease. Can Dioscin, a plant-based steroid, decrease the symptoms in mice?
Read More arrow_forwardInvestigating tau as the possible link between Alzheimer's Disease and diabetes. This protein, found in neurons, can 'clog up'.
Did you know that Alzheimer's and diabetes are linked? Patients with diabetes have an increased risk for Alzheimer's disease (AD) and patients with AD show impaired insulin function and glucose metabolism. The tau protein might be one of the connecting factors. This protein, found in neurons, can get hyperphosphorylated, causing it to tangle and 'clog up' the neuron - one of the pathological hallmarks of AD.
Serena Abbondante and her colleagues (The American Journal of Pathology, 2014) investigated the protein tau as a possible link between the two diseases, because according to them, recent evidence from animal models of diabetes shows that impaired insulin signaling causes tau hyperphosphorylation.
In order to investigate this relationship, they tested both non-transgenic (Ntg) mice as well as a knock-out strain for tau (tau-KO). From both groups a selection of mice were treated with streptozotocin (STZ), a chemical that causes a type 1 diabetes-like disease in mice. This resulted in four testing groups:
All four groups were tested for hippocampal dependent cognitive impairments in the Morris water maze test.
In the water maze, the platform was located at a fixed position. Mice were tested in four trials a day, placing them at a different starting location each time around, and were trained for as many days as it took for them to reach to platform within 25 seconds. Every time it took them longer than one minute to find the platform, they were guided to it and left there for 5 seconds. After the last training session a 60-second probe-trial was performed. This data was gathered and analyzed with EthoVision XT.
FREE TRIAL
Request a free trial and find out what EthoVision XT can do for your research!
The Ntg STZ mice showed impaired learning in the water maze compared to the untreated Ntg mice. Within the tau-KO group the treatment with STZ did not have this effect. Interestingly, the Ntg mice performed better than both tau-KO groups, (completing the training in 3 versus 4 days), while Ntg STZ mice did not reach the training criterion after five days. This indicates that the removal of tau mitigates the negative effects of STZ on learning in mice.
Looking at the results of this study, one might conclude that getting rid of the tau protein prevents the negative effects that diabetes can have on memory, however, it is not that simple. Tau has a function in the human body, serving as a binding factor between microtubules, providing structure and flexibility in the axons of the neuron. Interestingly though, the tau-knockout mice in this study did not show behavioral or synaptic disabilities…
At the very least, this study indicates that tau is an important key in the interaction between Alzheimer's and diabetes, making it an interesting target for new patient treatments.
Learn more about this study:
Researchers are constantly looking for new ways to treat Alzheimer's disease. Can Dioscin, a plant-based steroid, decrease the symptoms in mice?
Read More arrow_forward
Contrary to common methods, gait analysis can detect clinically relevant symptoms early on, researchers say.
Read More arrow_forward
As a potential Alzheimer medicine, betaine was tested on an AD animal model in a novel object recognition test. Using video tracking, scientists studied the influence of betaine and betaine transporter on mouse memory.
Read More arrow_forwardWe'll get back to you shortly.
Please correct the following errors: